Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - The company is a market leader in property and casualty insurance, with a solid competitive advantage. The continuous optimization of the structure of auto and non-auto insurance, along with effective cost control, has led to sustained underwriting profitability. In the life insurance sector, the bank insurance channel has significantly improved the quality and driven strong growth in new business value (NBV) [2][6]. - The company achieved a net profit attributable to the parent company of 46.65 billion yuan in 2025, representing a year-on-year increase of 8.8%. The comprehensive cost ratio for property and casualty insurance was 97.6%, a decrease of 0.9 percentage points year-on-year. The NBV for life insurance grew by 64.5% year-on-year, while the NBV for health insurance increased by 22.5% [6][12]. Summary by Relevant Sections Financial Performance - The company reported a total investment income of 92.32 billion yuan in 2025, an increase of 12.4% year-on-year, with an overall investment return rate of 5.7%, up by 0.1 percentage points year-on-year. The net investment return rate was 3.6%, down by 0.3 percentage points year-on-year. The allocation to stock investments increased significantly from 3.7% at the end of 2024 to 8.7%, effectively boosting overall performance [12]. - The property and casualty insurance segment achieved original insurance premium income of 555.78 billion yuan, a year-on-year growth of 3.3%, maintaining the industry's leading position. The underwriting profitability improved significantly, with the overall comprehensive cost ratio decreasing to 97.6% [12]. Life and Health Insurance - The company adjusted the risk discount rate assumption from a uniform 8.5% to 8.5% for traditional insurance and 7.5% for participating and universal insurance. On a comparable basis, the NBV for life insurance grew by 64.5% year-on-year, driven by a 41.4% increase in new long-term insurance policies through bank insurance channels and a 66.3% increase in periodic payments [12]. - The NBV for health insurance also saw a year-on-year increase of 22.5%, maintaining a leading position in the health insurance market [12]. Capital Adequacy and Dividends - As of the end of 2025, the core solvency ratios for the group, property and casualty insurance, and life insurance were 201.3%, 213.4%, and 134%, respectively, all significantly above regulatory requirements. The company proposed a dividend of 0.22 yuan per share, a year-on-year increase of 22.2%, with a dividend payout ratio of 20.9%, up by 2.3 percentage points year-on-year [12]. Future Outlook - The company is expected to continue benefiting from improvements in both assets and liabilities, leading to performance growth and valuation upside. The property and casualty insurance business remains a market leader, with ongoing optimization in the structure of auto and non-auto insurance and effective cost control [2][12].

Investment Rating - The insurance sector is rated as "Recommended," with expectations for the industry index to outperform the benchmark index by over 5% in the next 3-6 months [23]. Core Insights - The insurance sector showed overall profit growth in 2025, with a total net profit of 455.5 billion yuan from seven domestic listed insurance companies, marking a year-on-year increase of 26% [1]. - The fourth quarter was impacted by investment volatility, with only China Pacific Insurance achieving profit growth, while others faced declines [1]. - The dividend distribution varied among companies, with a total of 94.3 billion yuan in dividends, a 19% increase year-on-year, and most companies maintaining stable per-share dividends [2]. - New business value (NBV) for life insurance grew generally over 20%, driven by network expansion and improved value rates [3]. - The combined ratio (COR) for property insurance improved, although Sunshine Insurance was affected by credit insurance business [3]. - Net investment returns were influenced by declining interest rates, but equity assets positively impacted overall investment returns [4]. - The insurance sector is currently undervalued, with attractive dividend yields, and is recommended for continued attention [4]. Summary by Sections Annual Performance Overview - In 2025, the total net profit for seven listed insurance companies reached 455.5 billion yuan, with notable growth rates from China Taiping (+221%) and China Life (+44%) [1]. - The fourth quarter saw significant performance disparities, with only China Pacific Insurance reporting profit growth [1]. Dividend Distribution - Total dividends for the seven major insurance companies and China Property Insurance amounted to 94.3 billion yuan, reflecting a 19% year-on-year increase [2]. - Most companies achieved stable growth in per-share dividends, with varying dividend payout ratios [2]. New Business Value and Growth - The new business value for life insurance companies showed robust growth, with China Life at +35.7% and Ping An at +29.3% [3]. - The growth in new business value was supported by network expansion and the integration of individual insurance and health insurance [3]. Investment Returns - Net investment returns were affected by a downward trend in interest rates, but equity investments helped boost overall returns [4]. - The total investment return rates varied among companies, with China Life achieving a 6.09% return, an increase of 0.59 percentage points [4]. Market Outlook - The insurance sector is viewed as undervalued with attractive dividend yields, suggesting a favorable investment environment [4].

Summary of Key Points Core Viewpoint - Ping An Insurance reported a solid performance in 2025, with a notable increase in operating profit and new business value, despite challenges in the fourth quarter due to market volatility and one-time project impacts [1][2]. Financial Performance - The group achieved a parent operating profit (OPAT) of CNY 134.415 billion, up 10.3% year-on-year, with a Q4 increase of 35.3% [1]. - The net profit attributable to the parent company was CNY 134.778 billion, reflecting a year-on-year growth of 6.5%, but a significant decline of 74.1% in Q4 [1]. - The new business value (NBV) for life and health insurance reached CNY 36.897 billion, up 29.3% year-on-year [1][3]. - The combined ratio (COR) for property insurance improved to 96.8%, a 1.5 percentage point enhancement year-on-year [1][4]. Business Segments - Life and Health Insurance: - Operating profit was CNY 99.752 billion, a 2.9% increase year-on-year, driven by a 55.5% rise in investment service performance [3]. - The NBV growth was attributed to a significant increase in value rate, with the NBVM rising by 4.9 percentage points to 23.4% [3]. - The agent channel's NBV grew by 10.4%, while the bank insurance channel saw a remarkable increase of 138.0% [3]. - Property Insurance: - Operating profit reached CNY 16.923 billion, up 13.2% year-on-year, with stable growth in insurance service revenue of CNY 338.912 billion, a 3.3% increase [4]. - The overall cost ratio improved due to optimized expenses and profitability in the auto insurance segment [4]. Investment Performance - The total investment income increased by 13.5%, with a comprehensive investment return of 6.3%, up 0.5 percentage points year-on-year [5]. - The investment portfolio exceeded CNY 6.49 trillion, reflecting a 13.2% increase from the beginning of the year [5]. Dividend Distribution - The company proposed a cash dividend of CNY 1.75 per share at the end of 2025, leading to a total annual cash dividend of CNY 2.70 per share, a 5.9% increase year-on-year [1]. Future Projections - The company maintains its revenue forecasts for 2026-2027 at CNY 607.47 billion and CNY 635.135 billion, respectively, with an additional forecast for 2028 at CNY 653.611 billion [6]. - The net profit projections for 2026-2027 are set at CNY 147.09 billion and CNY 160.582 billion, with a new forecast for 2028 at CNY 169.706 billion [6].

Investment Rating - The investment rating for China Pacific Insurance (601601) is "Buy" (maintained) [1] Core Insights - The report highlights that the company's profit performance in Q4 significantly outperformed peers, with a full-year growth in New Business Value (NBV) exceeding 40% [1] - The report provides a detailed financial forecast for the years 2024 to 2028, indicating a steady increase in revenue and net profit [1][8] - The company is expected to maintain a focus on high-quality development and optimize its product structure, which supports the positive investment outlook [8] Financial Performance Summary - **Revenue Forecast**: Projected revenues for 2024, 2025, 2026, 2027, and 2028 are 404,089 million, 435,156 million, 448,705 million, 459,469 million, and 470,653 million respectively, with year-on-year growth rates of 24.74%, 7.69%, 3.11%, 2.40%, and 2.43% [1] - **Net Profit**: Expected net profits for the same years are 44,960 million, 53,505 million, 59,055 million, 62,093 million, and 65,248 million, reflecting growth rates of 64.95%, 19.01%, 10.37%, 5.15%, and 5.08% [1] - **Embedded Value (EV)**: The projected EV per share for 2024 to 2028 is 58.42, 63.76, 68.83, 74.72, and 81.31 respectively [1] - **Price-to-Earnings (P/E) Ratio**: The P/E ratios for 2024 to 2028 are 7.94, 6.67, 6.04, and 5.75, indicating a low valuation [1][8] Business Segment Insights - **Life Insurance**: The new business premium increased by 14.3% in 2025, with significant growth in the bancassurance channel, which accounted for 43.1% of new business premiums [8] - **Property and Casualty Insurance**: The combined ratio improved to 97.5%, with underwriting profits increasing by over 80% [8] - **Investment Strategy**: The company has increased its allocation to bonds and core equities while reducing exposure to non-standard investments [8]

Core Viewpoint - China Pacific Insurance (00966) reported an unexpectedly strong annual report, with a 220.9% year-on-year increase in net profit attributable to shareholders for 2025 and a more than 250% increase in per-share dividend from HKD 0.35 to HKD 1.23 [1] Group 1: Financial Performance - The company significantly increased its dividend level, exceeding market expectations, reflecting management's confidence in future business growth and solvency [1] - Investment business profits grew by 150% year-on-year, while underwriting financial losses narrowed by 14%, leading to a notable improvement in investment performance [1] - Tax optimization led to a reduction in the tax rate from 42.2% to -9.5%, resulting in a substantial release of tax-exempt income [1] Group 2: Value Metrics - New business value (NBV) increased by 5.3%, with the new business value rate rising to 21.3% [1] - Embedded value (EV) grew by 19.8%, outpacing industry peers, with the positive contribution from investment deviations increasing from 1.1% to 8.6% [1] - The company's net assets increased by 33.9%, indicating continuous improvement in the balance sheet [1]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a net profit attributable to shareholders of CNY 154.08 billion for 2025, representing a year-on-year increase of 44.1%. However, the Q4 net profit was a loss of CNY 13.73 billion, primarily due to adjustments in the capital market [2] - The company's embedded value reached CNY 1.47 trillion, up 4.8% year-on-year, while the new business value (NBV) was CNY 45.75 billion, reflecting a 35.7% increase [2] - The company plans to distribute a cash dividend of CNY 0.618 per share for the end of 2025, which, combined with the interim dividend, totals CNY 0.856 per share for the year, amounting to approximately CNY 24.2 billion, or 16% of the net profit [2] Summary by Sections New Business Value (NBV) - The company achieved a new business value of CNY 45.75 billion in 2025, a 35.7% increase year-on-year. The growth rates for Q1, H1, and Q1-3 were +4.8%, +20.3%, and +41.8% respectively. The new single premium was CNY 234.08 billion, up 9.3% year-on-year [3] - The individual insurance channel's NBV increased by 25.5% to CNY 39.30 billion, while other channels saw a 169.3% increase to CNY 6.45 billion, contributing 14% to the total NBV [3] Investment Performance - As of the end of the reporting period, the company's investment assets totaled CNY 7.42 trillion, a 12.3% increase from the beginning of the year. The total investment income was CNY 387.69 billion, a 25.8% increase year-on-year, while net investment income decreased by 1.0% to CNY 193.80 billion [4] - The total investment return rate reached 6.09%, an increase of 0.6 percentage points year-on-year [4] Financial Forecasts - The company maintains its forecasts for insurance service revenue at CNY 220.5 billion for 2026 and CNY 230.4 billion for 2027, with a new forecast of CNY 239.1 billion for 2028. The net profit forecasts are CNY 130.4 billion for 2026 and CNY 133.3 billion for 2027, with a new forecast of CNY 135.0 billion for 2028 [5] - The earnings per share (EPS) forecasts are CNY 4.61 for 2026, CNY 4.72 for 2027, and CNY 4.78 for 2028 [5]

Core Viewpoint - China Ping An's performance metrics highlight a strong growth trajectory in personal customer numbers, which is a key focus for the company, alongside significant increases in operational profits and shareholder equity [2]. Financial Performance - For the year ending December 31, 2025, China Ping An reported a net operating profit of 134.415 billion RMB, a year-on-year increase of 10.3% - The net profit attributable to shareholders, excluding non-recurring items, reached 143.773 billion RMB, reflecting a year-on-year growth of 22.5% - Shareholder equity surpassed 1 trillion RMB for the first time, growing by 7.7% from the beginning of the year [2]. - The proposed final dividend for 2025 is 1.75 RMB per share, with a total cash dividend of 2.70 RMB per share, marking a 5.9% increase year-on-year, totaling 48.891 billion RMB in cash dividends, which represents 36.4% of the net operating profit [2]. Customer Growth - The number of personal customers increased from 222 million at the end of 2021 to 251 million by the end of 2025, a growth of 3.5%, equating to approximately 18 customers per 100 people [2]. - The composition of customers showed growth in protection, asset, and service categories by 3.9%, 2.5%, and 4.0% respectively, while credit customers decreased due to strategic adjustments in response to industry cycles [2]. Product Engagement - The average number of contracts per customer in 2025 was 2.94, an improvement from 2024 but still below the levels seen in 2022 and 2023 - Higher contract numbers correlate with increased customer retention, with retention rates of 97% for customers holding two product types and 99% for those with three or more [3]. - The new business value for life and health insurance reached 36.897 billion RMB, a year-on-year increase of 29.3%, with a new business value rate of 28.5%, up by 5.8 percentage points [3]. Investment Performance - As of the end of 2025, the investment portfolio of insurance funds totaled 6.49 trillion RMB, a growth of 13.2% from the beginning of the year - The comprehensive investment return rate was 6.3%, an increase of 0.5 percentage points year-on-year, attributed to a balanced asset allocation strategy and an increased proportion of equity investments - The net investment return rate was 3.7%, a slight decline of 0.1 percentage points, primarily due to the maturity of existing assets and a decrease in yields from newly added fixed-income assets [4].

Investment Rating - The report assigns a "Buy-A/Buy-H" rating for the company [3] Core Views - The company's performance and value are both strong, with dividend growth exceeding expectations [1] - The net profit for 2025 increased by 44.1% year-on-year, driven by market upturns and increased equity allocation [12][44] - The new business value (NBV) grew by 35.7% year-on-year, supported by a strong demand for savings products and improved distribution channels [30][46] Financial Forecast - Embedded Value (CNY million) is projected to grow from 1,401,146 in 2024 to 1,960,695 in 2028, with a growth rate of 11.2% in 2024 [2] - Net profit is expected to reach 106,935 million in 2024, with a significant increase of 131.56% year-on-year [2] - Earnings per share (EPS) is forecasted to be 3.78 in 2024, increasing to 6.01 by 2028 [2] Performance Analysis - The company's total investment assets reached 7.42 trillion, a 12.3% increase year-on-year, with a notable rise in equity investments [22] - The total investment return for 2025 was 6.1%, reflecting a 0.6 percentage point increase from the previous year [25] - The company’s net investment yield was 3% in 2025, supported by a higher allocation to high-dividend assets [25] Value Analysis - The NBV for 2025 is projected at 45,752 million, with a year-on-year increase of 35.7% [2][30] - The company's internal value (EV) increased by 4.8% year-on-year, despite negative market value adjustments due to rising interest rates [35][46] - The NBV margin improved to 19.5%, up 3.8 percentage points year-on-year, driven by better pricing and distribution strategies [30][34] Insurance Sector Insights - The company’s agent workforce decreased by 4.6% year-on-year to 587,000, but the quality of agents is improving [41][42] - The company is focusing on enhancing the quality of its sales force while expanding its market presence [41] Profitability Forecast and Investment Recommendations - The report anticipates significant net profit growth, with EPS expected to be 4.42, 5.93, and 6.01 for 2026, 2027, and 2028 respectively [2][44] - The fair value for A-shares is estimated at 56.53 CNY and for H-shares at 38.45 HKD, maintaining a "Buy" rating [44][46]

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of China Life Insurance, with current prices at 39.49 RMB and 27.36 HKD respectively [1]. Core Insights - In 2025, China Life Insurance achieved an operating revenue of 615.68 billion RMB, a year-on-year increase of 16.5%. The net profit attributable to shareholders reached 154.08 billion RMB, up 44.1% year-on-year [4]. - The new business value (NBV) grew by 35.7% year-on-year to 45.75 billion RMB, indicating robust growth in new business despite a slight slowdown in the growth rate compared to previous quarters [6][7]. - The company’s total investment assets reached 7.4 trillion RMB, with a significant increase in stock assets, which rose by 66.7% year-on-year [6]. Financial Performance - The net investment yield was 3.0%, down 0.4 percentage points year-on-year, while the total investment yield increased by 0.6 percentage points to 6.1% [7]. - The company’s return on equity (ROE) was 27.8%, an increase of 6.2 percentage points year-on-year, reflecting improved profitability [4]. - The dividend per share was 0.856 RMB, a 31.7% increase year-on-year, with a payout ratio of 15.7%, down 1.5 percentage points [4]. Business Development - The company is focusing on marketing system reforms, with a total sales force of 638,000, a decrease of 4.2% year-on-year. However, the quality of the sales force is improving, with a 40% increase in high-performing agents [4]. - The proportion of floating income-type business in the first-year premium has approached 50%, indicating a successful transformation in product structure [5][6]. - The company is actively exploring innovations in the health and elderly care sectors, which are expected to further enhance its core insurance business [7]. Future Projections - The report forecasts a continued growth trend in new business value for 2026, with adjusted net profit estimates for 2026 and 2027 at 161.3 billion RMB and 174.3 billion RMB respectively [7]. - The projected operating revenue for 2026 is 651.3 billion RMB, with a growth rate of 5.78% [9].

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Insights - The company is expected to achieve significant growth in both profit and value by the end of 2025, with projected revenue of 615.68 billion yuan, a year-on-year increase of 16.5%, and a net profit of 154.08 billion yuan, reflecting a 44.1% growth [1] - The New Business Value (NBV) has shown strong growth, reaching 45.75 billion yuan in 2025, a substantial increase of 35.7%, marking the highest growth rate since 2017 [2] - The company has significantly increased its equity asset allocation, with the proportion of stocks and funds rising from 12.18% at the end of 2024 to 16.89% by the end of 2025, leading to a total investment return rate of 6.09%, up by 59 basis points year-on-year [3] Financial Performance and Forecast - The company forecasts revenue growth from 528.57 billion yuan in 2024 to 615.68 billion yuan in 2025, with a projected net profit increase from 106.94 billion yuan to 154.08 billion yuan during the same period [4] - The diluted earnings per share (EPS) are expected to rise from 5.45 yuan in 2025 to 6.87 yuan by 2028, with corresponding price-to-earnings (P/E) ratios decreasing from 7.21 to 5.72 [6]